Commentary: Old Self vs. New Self

Implantation of deep brain stimulator (DBS) leads for Gilles de Tourette syndrome was first described by Visser-Vanderwalle et al., with a reported 70%–90% decrease in tic frequency.1 Since that time, several targets, including the basal/ganglia and striatum, have been described. The target remains...

Full description

Saved in:  
Bibliographic Details
Main Author: Beasley, Kara D. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Cambridge Univ. Press 2016
In: Cambridge quarterly of healthcare ethics
Year: 2016, Volume: 25, Issue: 4, Pages: 751-753
Online Access: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000naa a22000002 4500
001 1827973684
003 DE-627
005 20221220052642.0
007 cr uuu---uuuuu
008 221220s2016 xx |||||o 00| ||eng c
024 7 |a 10.1017/S0963180116000517  |2 doi 
035 |a (DE-627)1827973684 
035 |a (DE-599)KXP1827973684 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Beasley, Kara D.  |e VerfasserIn  |4 aut 
245 1 0 |a Commentary: Old Self vs. New Self 
264 1 |c 2016 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Implantation of deep brain stimulator (DBS) leads for Gilles de Tourette syndrome was first described by Visser-Vanderwalle et al., with a reported 70%–90% decrease in tic frequency.1 Since that time, several targets, including the basal/ganglia and striatum, have been described. The target remains experimental, and in this case, leads were implanted under an investigator-initiated research protocol. Ms. L. reported an excellent intraoperative reduction in the “urge to tic” that persisted for 15 weeks postoperatively, indicating that the leads were well placed. Furthermore, although her tic frequency has increased, it remains improved from baseline and returns to baseline when stimulation is discontinued. Although her response does not represent what her treatment team would consider the “desired medical/therapeutic outcomes,” there is no question that the patient recognizes benefit from her stimulation. In fact, she clearly states that “it’s like I’ve felt a new way and don’t want to go back to the old way.” 
773 0 8 |i Enthalten in  |t Cambridge quarterly of healthcare ethics  |d Cambridge : Cambridge Univ. Press, 1992  |g 25(2016), 4, Seite 751-753  |h Online-Ressource  |w (DE-627)306655039  |w (DE-600)1499985-7  |w (DE-576)081985010  |x 1469-2147  |7 nnns 
773 1 8 |g volume:25  |g year:2016  |g number:4  |g pages:751-753 
856 4 0 |u https://doi.org/10.1017/S0963180116000517  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.cambridge.org/core/journals/cambridge-quarterly-of-healthcare-ethics/article/commentary-old-self-vs-new-self/CAC14D99CF4FAE75A692546F71677D10  |x Verlag  |z lizenzpflichtig  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4235378597 
LOK |0 003 DE-627 
LOK |0 004 1827973684 
LOK |0 005 20221220052642 
LOK |0 008 221220||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-12-06#F830302DFFD3015F2647FEDEA83606100A9149C7 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
ORI |a SA-MARC-ixtheoa001.raw